BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35436936)

  • 1. Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada.
    Minoyan N; Høj SB; Zolopa C; Vlad D; Bruneau J; Larney S
    Harm Reduct J; 2022 Apr; 19(1):38. PubMed ID: 35436936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.
    Otiashvili D; Mgebrishvili T; Beselia A; Vardanashvili I; Dumchev K; Kiriazova T; Kirtadze I
    Harm Reduct J; 2022 Mar; 19(1):25. PubMed ID: 35264181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.
    Ali F; Russell C; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    Int J Drug Policy; 2021 Jul; 93():103237. PubMed ID: 33893026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
    Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with changes in illicit opioid use during the COVID-19 pandemic among incarcerated people who use drugs in Quebec, Canada.
    Park H; Linthwaite B; Dussault C; Halavrezos A; Chalifoux S; Sherman J; Del Balso L; Buxton JA; Cox J; Kronfli N
    Int J Prison Health; 2022 Dec; 19(3):464-73. PubMed ID: 36519779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).
    Moreheart S; Shannon K; Krüsi A; McDermid J; Ettinger E; Braschel M; Goldenberg SM
    Int J Drug Policy; 2023 Nov; 121():104212. PubMed ID: 37797570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-related harm coinciding with income assistance payments: results from a community-based cohort of people who use drugs.
    Richardson L; Dong H; Kerr T; Milloy MJ; Hayashi K
    Addiction; 2021 Mar; 116(3):536-545. PubMed ID: 32621376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada.
    Cassie R; Hayashi K; DeBeck K; Milloy MJ; Cui Z; Strike C; West J; Kennedy MC
    Harm Reduct J; 2022 Nov; 19(1):126. PubMed ID: 36401299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
    Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
    Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
    Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
    BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada.
    Pilarinos A; Barker B; Nosova E; Milloy MJ; Hayashi K; Wood E; Kerr T; DeBeck K
    Addiction; 2020 Jan; 115(1):97-106. PubMed ID: 31379008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'More of the same, but worse than before': A qualitative study of the challenges encountered by people who use drugs in Nova Scotia, Canada during COVID-19.
    Comeau E; Bonn M; Wildeman S; Herder M
    PLoS One; 2023; 18(4):e0283979. PubMed ID: 37018353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
    Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
    Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the COVID-19 pandemic on access to supervised consumption programs.
    Gubskaya E; Kennedy MC; Hayashi K; Cui Z; Milloy MJ; Kerr T
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):16. PubMed ID: 36899417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid review of the impacts of "Big Events " on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19.
    Zolopa C; Hoj S; Bruneau J; Meeson JS; Minoyan N; Raynault MF; Makarenko I; Larney S
    Int J Drug Policy; 2021 Jun; 92():103127. PubMed ID: 33549464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illicit drug use while admitted to hospital: Patient and health care provider perspectives.
    Strike C; Robinson S; Guta A; Tan DH; O'Leary B; Cooper C; Upshur R; Chan Carusone S
    PLoS One; 2020; 15(3):e0229713. PubMed ID: 32134973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016-20.
    Price O; Man N; Bruno R; Dietze P; Salom C; Lenton S; Grigg J; Gibbs D; Wilson T; Degenhardt L; Chan R; Thomas N; Peacock A
    Addiction; 2022 Jan; 117(1):182-194. PubMed ID: 34159666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island.
    Collins AB; Edwards S; McNeil R; Goldman J; Hallowell BD; Scagos RP; Marshall BDL
    Int J Drug Policy; 2022 May; 103():103626. PubMed ID: 35228056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health service utilisation and access for people who inject drugs during COVID-19.
    Efunnuga H; Higgs P; Walker S; O'Keefe D
    Drug Alcohol Rev; 2022 Sep; 41(6):1304-1310. PubMed ID: 35266229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.